The Board of Commissioners of
The lawsuit filed against
The lawsuit also alleged Halifax knowingly acted in violation of the law by paying three neurosurgeons more than fair market value for their work, and that the hospital admitted patients who did not need to be admitted and then billed Medicare for their care.
Because of the complexity and breadth of the lawsuit, U.S. District Judge Gregory Presnell agreed to split the case into two trials: one focusing on bonuses paid to the oncologists and on the alleged excessive compensation paid to the three neurosurgeons, and a second focusing on the fraudulent billing for patients who were unnecessarily admitted to the hospital.
The first trial was scheduled to begin March 3, but just before the jury was seated, Halifax and prosecutors came to a settlement agreement for $85 million.
Although
"We are disappointed in paying anything for providing exception care, but we are looking forward to putting this behind us and moving forward," said Jeff Feasel, CEO of Halifax, in a statement.
The final step in resolving the case is having the settlement entered in federal court in
More Articles on Healthcare Industry Lawsuits:
5 Recent Employee Whistle-Blower Cases
Fourth Circuit Contradicts D.C. Circuit Concerning PPACA Subsidies
Infirmary Health System to Pay $24.5M to Settle FCA, Stark Law and Anti-Kickback Allegations